These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20035028)

  • 1. Soluble epoxide hydrolase inhibition modulates vascular remodeling.
    Simpkins AN; Rudic RD; Roy S; Tsai HJ; Hammock BD; Imig JD
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H795-806. PubMed ID: 20035028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.
    Revermann M; Schloss M; Barbosa-Sicard E; Mieth A; Liebner S; Morisseau C; Geisslinger G; Schermuly RT; Fleming I; Hammock BD; Brandes RP
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):909-14. PubMed ID: 20224052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.
    Koeners MP; Wesseling S; Ulu A; Sepúlveda RL; Morisseau C; Braam B; Hammock BD; Joles JA
    Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E691-8. PubMed ID: 21266668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.
    Simpkins AN; Rudic RD; Schreihofer DA; Roy S; Manhiani M; Tsai HJ; Hammock BD; Imig JD
    Am J Pathol; 2009 Jun; 174(6):2086-95. PubMed ID: 19435785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosis.
    Li L; Li N; Pang W; Zhang X; Hammock BD; Ai D; Zhu Y
    PLoS One; 2014; 9(4):e94092. PubMed ID: 24718617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration.
    Wang Q; Huo L; He J; Ding W; Su H; Tian D; Welch C; Hammock BD; Ai D; Zhu Y
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1894-903. PubMed ID: 26453326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.
    Revermann M; Barbosa-Sicard E; Dony E; Schermuly RT; Morisseau C; Geisslinger G; Fleming I; Hammock BD; Brandes RP
    J Hypertens; 2009 Feb; 27(2):322-31. PubMed ID: 19226702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA; Faulkner J; Pye C; Rouch K; Alhashim A; Maddipati KR; Baban B
    Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat.
    Corenblum MJ; Wise VE; Georgi K; Hammock BD; Doris PA; Fornage M
    Hypertension; 2008 Feb; 51(2):567-73. PubMed ID: 18086949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.
    Manhiani M; Quigley JE; Knight SF; Tasoobshirazi S; Moore T; Brands MW; Hammock BD; Imig JD
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F740-8. PubMed ID: 19553349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation.
    Zhang LN; Wilson DW; da Cunha V; Sullivan ME; Vergona R; Rutledge JC; Wang YX
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):765-72. PubMed ID: 16456092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
    Dorrance AM; Rupp N; Pollock DM; Newman JW; Hammock BD; Imig JD
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):842-8. PubMed ID: 16306811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization of interleukin-18 inhibits neointimal formation in a rat model of vascular injury.
    Maffia P; Grassia G; Di Meglio P; Carnuccio R; Berrino L; Garside P; Ianaro A; Ialenti A
    Circulation; 2006 Aug; 114(5):430-7. PubMed ID: 16864728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ.
    Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC
    Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.
    Sun D; Cuevas AJ; Gotlinger K; Hwang SH; Hammock BD; Schwartzman ML; Huang A
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1146-53. PubMed ID: 24561863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
    Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats.
    Fornage M; Hinojos CA; Nurowska BW; Boerwinkle E; Hammock BD; Morisseau CH; Doris PA
    Hypertension; 2002 Oct; 40(4):485-90. PubMed ID: 12364351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble epoxide hydrolase deletion attenuated nicotine-induced arterial stiffness via limiting the loss of SIRT1.
    Hu S; Luo J; Fu M; Luo L; Cai Y; Li W; Li Y; Dong R; Yang Y; Tu L; Xu X
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H353-H368. PubMed ID: 34142887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.
    Elmarakby AA; Faulkner J; Al-Shabrawey M; Wang MH; Maddipati KR; Imig JD
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1307-17. PubMed ID: 21832210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
    Fife KL; Liu Y; Schmelzer KR; Tsai HJ; Kim IH; Morisseau C; Hammock BD; Kroetz DL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):707-15. PubMed ID: 18815352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.